SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending sharply upward ahead of its highly anticipated earnings report later today, with the community divided between strong bullish sentiment driven by massive AI demand and new product excitement, and cautious predictions of a "sell the news" event following the recent rally.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending with high community anticipation for upcoming ASCO GU data on its ANKTIVA immunotherapy. Many expect this data to solidify the drug's position as a standard-of-care backbone for various cancers, driving strong conviction and 'buy the dip' sentiment despite persistent short pressure.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending amid a significant stock price decline, fueling community debate over broader software sector weakness and perceived threats from AI, contrasted by conviction from investors who highlight strong fundamentals, strategic AI pivots, and upcoming earnings as catalysts for a major rebound and short squeeze.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is trending after reporting strong quarterly earnings that surpassed expectations, showcasing robust growth in USDC adoption and transaction volume, which has ignited bullish sentiment and discussions around its pivotal role as foundational digital dollar infrastructure amid debates on its valuation and market sensitivity.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is drawing significant attention after its Friedreich's ataxia drug, nomlabofusp, received FDA Breakthrough Therapy Designation, fueling bullish price target increases and active community discussion on its potential as a blockbuster, even with ongoing debate about managing side effects.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending after its latest earnings revealed impressive revenue growth, particularly in diagnostics, and a record total contract value with pharma partners for its AI-driven oncology platform. However, a wider net loss and anticipated slower revenue growth are sparking a debate among investors, with many seeing a buy-the-dip opportunity fueled by institutional interest and short-squeeze potential.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is highly discussed after an announced $175 million private equity placement caused a share price drop. Many in the community are debating whether the market's reaction to the dilution is an overcorrection, particularly as the funds are earmarked for strategic growth in space infrastructure and lunar services, including potential NASA contracts like the Lunar Terrain Vehicle award.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA Group is trending following strong Q4 earnings that surpassed analyst expectations, fueled by double-digit revenue growth and upbeat FY26 guidance for restaurant expansion and same-store sales. The market is buzzing with a perceived short squeeze, as bulls celebrate the upward momentum and increased price targets, while some express skepticism over the stock's high valuation despite its growth in the fast-casual dining sector.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech Ltd. is trending after a dramatic share price fall, driven by a forecast of substantial revenue decline in the upcoming quarter due to an advertising algorithm issue, as the community intensely debates if the sell-off is an overreaction or signals deeper concerns about the company's operational integrity.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon Enterprise is trending due to strong financial results and an upbeat multi-year outlook, particularly highlighting its expanding AI-powered public safety ecosystem. The community is actively discussing a significant short squeeze, seeing the company's hardware-software integration and market dominance as a key long-term growth story.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit

POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit POM Investors with Large Losses Should Contact Robbins LLP for...

POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit

POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit PR Newswire NEW YORK, Feb. 23, 2026 NEW...

POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026

POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP...

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM)

Scott+Scott Attorneys at Law LLP (Scott+Scott), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants PomDoctor...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines - POM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines - POM INVESTOR ALERT: Pomerantz Law Firm Reminds...

Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately

Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately Shareholders who lost money in American Depositary Receipts of...

POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026

POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP...

POM Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against POMDoctor Ltd.

POM Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against POMDoctor Ltd. POM Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against POMDoctor Ltd. PR...

PomDoctor Ltd. operates as an online medical services platform, which specializes in chronic disease management and pharmaceutical services. It operates through two segments: Internet hospital and pharmaceutical supply chain. The Internet hospital segment include online consultation and prescription renewal and CDM service. The pharmaceutical supply chain provides other pharmaceutical platforms with supply chain management and platform operation services. The company was founded by Zhenyang Shi and Li Xu on February 01, 2021 and is headquartered in Guangzhou, China.

Pomdoctor Ltd. - ADR

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

Current Price	$0.246
Prev Close	$0.248
Open	$0.2311
Dividend Yield	N/A
50-Day Moving Average	$0.2866
Beta	-10.26
Avg. Volume	467,365.25
PE Ratio	N/A

52-Week High	$6.43
52-Week Low	$0.193
Market Capitalization	$26.52M
EPS (Annual)	-$0.1682
Price to Book	N/A
Revenue Per Employee	$305,118.77

POM
Pomdoctor Limited

Feed

News

Sentiment

Fundamentals

Info

Latest POM News

POMPomdoctor Limited